Related Experiment Video
Updated: Oct 15, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Genistein: A Potent Anti-Breast Cancer Agent
Smitha S Bhat1, Shashanka K Prasad1, Chandan Shivamallu1
1Department of Biotechnology and Bioinformatics, Faculty of Life Sciences, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.
Abstract:
Genistein is an isoflavonoid present in high quantities in soybeans. Possessing a wide range of bioactives, it is being studied extensively for its tumoricidal effects. Investigations into mechanisms of the anti-cancer activity have revealed many pathways including induction of cell proliferation, suppression of tyrosine kinases, regulation of Hedgehog-Gli1 signaling, modulation of epigenetic activities, seizing of cell cycle and Akt and MEK signaling pathways, among others via which the cancer cell proliferation can be controlled. Notwithstanding, the observed activities have been time- and dose-dependent. In addition, genistein has also shown varying results in women depending on the physiological parameters, such as the early or post-menopausal states.
Insights
Genistein, a soybean isoflavonoid, exhibits anti-cancer properties by influencing multiple cell signaling pathways. Its effectiveness in cancer treatment is dependent on dosage, timing, and individual patient factors.
Area of Science:
- Phytochemistry
- Molecular Biology
- Oncology
Background:
- Genistein is a prominent isoflavonoid found abundantly in soybeans.
- It possesses diverse bioactive properties, making it a subject of intense research for its potential anti-cancer effects.
Purpose of the Study:
- To investigate the multifaceted mechanisms underlying genistein's anti-cancer activity.
- To explore the signaling pathways modulated by genistein in controlling cancer cell proliferation.
Main Methods:
- Review of existing scientific literature on genistein's anti-cancer mechanisms.
- Analysis of pathways including cell proliferation, tyrosine kinases, Hedgehog-Gli1 signaling, epigenetics, cell cycle, and Akt/MEK pathways.
Main Results:
- Genistein's anti-cancer effects are mediated through various pathways, including modulation of cell proliferation and signaling cascades.
- Observed activities are contingent upon specific timeframes and dosages.
- Genistein's efficacy varies in women, influenced by physiological states like menopausal status.
Conclusions:
- Genistein demonstrates significant potential as an anti-cancer agent through diverse molecular mechanisms.
- Further research is warranted to optimize its therapeutic application, considering time, dose, and patient-specific factors.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

